2008
DOI: 10.1016/j.gcb.2008.01.028
|View full text |Cite
|
Sign up to set email alerts
|

Severe acute pancreatitis related to the use of adefovir in a liver transplant recipient

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2008
2008
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 8 publications
0
3
0
Order By: Relevance
“…DNA polymerase inhibitors are antiviral drugs used mainly to treat infections caused by herpes viruses (herpes simplex, varicella zoster, cytomegalovirus), but also for the treatment of hepatitis C and B [135,136]. Some agents in this class have been associated with the risk of developing AP; in particular, adefovir and famciclovir are the only ones included in the classifications discussed [135,136].…”
Section: Dna Polymerase Inhibitorsmentioning
confidence: 99%
See 1 more Smart Citation
“…DNA polymerase inhibitors are antiviral drugs used mainly to treat infections caused by herpes viruses (herpes simplex, varicella zoster, cytomegalovirus), but also for the treatment of hepatitis C and B [135,136]. Some agents in this class have been associated with the risk of developing AP; in particular, adefovir and famciclovir are the only ones included in the classifications discussed [135,136].…”
Section: Dna Polymerase Inhibitorsmentioning
confidence: 99%
“…DNA polymerase inhibitors are antiviral drugs used mainly to treat infections caused by herpes viruses (herpes simplex, varicella zoster, cytomegalovirus), but also for the treatment of hepatitis C and B [135,136]. Some agents in this class have been associated with the risk of developing AP; in particular, adefovir and famciclovir are the only ones included in the classifications discussed [135,136]. Adefovir, which is primarily used to treat hepatitis B, was classified as class Ic according to Wolfe et al because a case of severe AP associated with adefovir use in a liver transplant recipient was reported in 2008 [11].…”
Section: Dna Polymerase Inhibitorsmentioning
confidence: 99%
“…Other drugs commonly used in the post-operative period that could cause pancreatitis in the post-liver transplant population include azathioprine/6-mercaptopurine and furosemide (42)(43)(44)(45). Despite the range of drugs that could potentially cause drug-induced pancreatitis in the liver transplant population, only one paper identified a drug (adefovir) as a potential cause for drug-induced pancreatitis following liver transplantation (46). In fact, one study identified corticosteroids as a protective factor against PEP following liver transplantation (38).…”
Section: Drugsmentioning
confidence: 99%